Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Xu HongChief Financial Officer | Option exercise | M | — 62.0K sh | Mar 26, 2026 |
| 9 | Sragovicz AdamChief Financial Officer | Grant or award | A | — 100.4K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 9 | Wirfel MichelleEVP, Chief Operating Officer | Tax withholding | F | $10K 595 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 9 | Jiang FangChief People Officer | Option exercise | M | — 2,672 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 9 | Carter Susan KDirector | Grant or award | A | $3,186 45 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 9 | Hankin Michael DavidDirector | Grant or award | A | $11K 155 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 9 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | Option exercise | M | — 2,142 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 9 | Tomsic StevenChief Financial Officer | Grant or award | A | — 131 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 9 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | Option exercise | M | — 8,138 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 9 | Crew Debra AnnDirector | Grant or award | A | $8,917 126 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 8 | Low RussellDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $112K 1,244 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 8 | Raben DavidChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $104K 5,500 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 8 | Bowe Patrick E.Director | Open-market sale · 10b5-1 plan | SELL | $58K 800 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 6 | Owens Bradley D.General Counsel | Option exercise · 10b5-1 plan | M | $197K 8,800 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 5 | Nithrakashyap ArvindDirector, Chief Technology Officer | Option exercise | M | — 40.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 5 | Nithrakashyap ArvindDirector, Chief Technology Officer | Derivative conversion | C | — 40.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 5 | Nithrakashyap ArvindDirector, Chief Technology Officer | Option exercise | M | — 40.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 4 | Misra AmitabhChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $243K 41.7K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 3 | Balcom AlexandraChief Financial Officer | Option exercise · 10b5-1 plan | M | — 11.4K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 3 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 3 | Samuelson Errol GChief Industry Dev. Officer | Grant or award · 10b5-1 plan | A | — 7,912 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 3 | Balcom AlexandraChief Financial Officer | Option exercise · 10b5-1 plan | M | $12K 11.4K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Choudary Kiran KumarChief Financial Officer | Option exercise | M | — 7,188 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Soteropoulos PaulaDirector | Option exercise · 10b5-1 plan | M | $233K 27.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Choudary Kiran KumarChief Financial Officer | Derivative conversion | C | — 212.2K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Choudary Kiran KumarChief Financial Officer | Option exercise | M | — 212.2K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Mar 26, 2026 traded Mar 26, 2026 |
| 0 | Chutter Jessica CarolineDirector | Grant or award · 10b5-1 plan | A | — 3,475 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Raben DavidChief Medical Officer | Option exercise · 10b5-1 plan | M | $21K 5,500 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Mar 26, 2026 traded Mar 26, 2026 |
| 0 | Chutter Jessica CarolineDirector | Grant or award · 10b5-1 plan | A | — 4,000 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Soteropoulos PaulaDirector | Option exercise · 10b5-1 plan | M | — 27.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Owens Bradley D.General Counsel | Option exercise · 10b5-1 plan | M | — 8,800 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Chutter Jessica CarolineDirector | Grant or award · 10b5-1 plan | A | — 2,896 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 0 | Raben DavidChief Medical Officer | Option exercise · 10b5-1 plan | M | — 5,500 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 56 | Menell Richard PeterDirector | Open-market purchase | BUY | $29K 2,500 sh | Mar 25, 2026 traded Mar 24, 2026 |
| 50 | Angotti Vincent J.Director, CHIEF EXECUTIVE OFFICER | Open-market purchase | BUY | $125K 213.3K sh | Mar 25, 2026 traded Mar 13, 2026 |